PAUF as a Target for Treatment of High PAUF-Expressing Ovarian Cancer

PAUF as a Target for Treatment of High PAUF-Expressing Ovarian Cancer

Pancreatic adenocarcinoma up-regulated factor (PAUF) plays an important role in tumor growth, metastasis, and immune evasion in the pancreatic tumor microenvironment, and recent studies suggest an association between PAUF expression and poor prognosis in ovarian cancer patients. The current study ai...

Full description

Bibliographic Details
Main Authors:	Yeon Jeong Kim, Fen Jiang, Jin Park, Hyeon Hee Jeong, Ji Eun Baek, Seung-Mo Hong, Seong-Yun Jeong, Sang Seok Koh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Pharmacology
Subjects:	PAUF ovarian cancer molecular targeted therapy monoclonal antibody combination chemotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.890614/full

Similar Items

PAUF Induces Migration of Human Pancreatic Cancer Cells Exclusively via the TLR4/MyD88/NF-κB Signaling Pathway
by: So Eun Youn, et al.
Published: (2022-09-01)

Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma
by: Jihye Kim, et al.
Published: (2018-10-01)

Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression
by: Hyun Jung Kim, et al.
Published: (2019-07-01)

Sorting secretory proteins
by: Anup Parchure, et al.
Published: (2023-11-01)

A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer
by: Samantha M. Perez, et al.
Published: (2021-08-01)

Alternative treatment of chemoresistant, recurrent or advanced ovarian cancer. Part I
by: Jacek R. Wilczyński
Published: (2011-06-01)

Role of Stem Cells in the Ovarian Tissue Cryopreservation and Transplantation for Fertility Preservation
by: Jeong Min Kim, et al.
Published: (2021-11-01)

Synergistic Encapsulation of Paclitaxel and Sorafenib by Methoxy Poly(Ethylene Glycol)-<i>b</i>-Poly(Caprolactone) Polymeric Micelles for Ovarian Cancer Therapy
by: Chae Eun Jin, et al.
Published: (2023-04-01)

A Novel Antibody-Drug Conjugate Targeting Nectin-2 Suppresses Ovarian Cancer Progression in Mouse Xenograft Models
by: Yun Hee Sim, et al.
Published: (2022-10-01)

Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer
by: Maria Bonello, et al.
Published: (2018-12-01)

Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer
by: Myeong-Seon Kim, et al.
Published: (2022-09-01)

Nanoparticle-Based Combination Therapy for Ovarian Cancer
by: Wu Y, et al.
Published: (2023-04-01)

In vivo anti‐V‐ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses
by: Arpita Kulshrestha, et al.
Published: (2020-10-01)

Effect of seven oriental herbs mixture (Jogyeongbohyeoldan) on the restoration of ovarian aging in aged mice
by: Jong-Kil Joo, et al.
Published: (2021-02-01)

Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting
by: Hyun Jung Kim
Published: (2022-05-01)

Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles
by: Se Ik Kim, et al.
Published: (2020-12-01)

Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
by: Jieun Ko, et al.
Published: (2021-09-01)

Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma
by: Mihaljević Biljana, et al.
Published: (2008-01-01)

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
by: Yong Jae Lee, et al.
Published: (2020-03-01)

Generation of Monoclonal Antibodies for Sensitive Detection of Pro-Inflammatory Protein S100A9
by: Eun-Jung Kim, et al.
Published: (2021-05-01)

Regulatory T Cells in Ovarian Carcinogenesis and Future Therapeutic Opportunities
by: Emily Cassar, et al.
Published: (2022-11-01)

Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy
by: Chi Hun Song, et al.
Published: (2023-11-01)

Large-scale production of monoclonal antibodies in suspension culture /
by: 271860 Backer, M. P., et al.

Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell Lung Cancer
by: Kwang-Hyeok Kim, et al.
Published: (2022-02-01)

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
by: Soo Young Jeong, et al.
Published: (2019-12-01)

Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b
by: Kristina Levan, et al.
Published: (2017-05-01)

Effects of paclitaxel combined with carboplatin on expression of VEGF and tumor markers in ovarian cancer
by: TAN Shufen, YANG Xielan, YANG Linlin, LI Shuqing
Published: (2023-12-01)

Antibody-drug conjugates for cancer therapy
by: Anna Grzywa
Published: (2021-11-01)

Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial
by: Elizabeth H. Phillips, et al.
Published: (2020-07-01)

Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives
by: Rafieh Bagherifar, et al.
Published: (2021-04-01)

Monoclonal antibodies : the second generation /
by: 186276 Zola, Heddy
Published: (1995)

Prediction of Successful Ovarian Protection Using Gonadotropin-Releasing Hormone Agonists During Chemotherapy in Young Estrogen Receptor-Negative Breast Cancer Patients
by: Dong-Yun Lee, et al.
Published: (2020-06-01)

Real-World Experience of the Comparative Effectiveness and Safety of Combination Therapy with Remdesivir and Monoclonal Antibodies versus Remdesivir Alone for Patients with Mild-to-Moderate COVID-19 and Immunosuppression: A Retrospective Single-Center Study in Aichi, Japan
by: Jun Hirai, et al.
Published: (2023-09-01)

Nonconvulsive status epilepticus associated with leptomeningeal carcinomatosis and positive SOX1 antibodies
by: Jeong Yeon Kim, et al.
Published: (2020-06-01)

Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal Period
by: Clémence Disdier, et al.
Published: (2018-06-01)

Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study
by: Yong Jae Lee, et al.
Published: (2022-07-01)

Impact of CT-Determined Sarcopenia and Body Composition on Survival Outcome in Patients with Advanced-Stage High-Grade Serous Ovarian Carcinoma
by: Se Ik Kim, et al.
Published: (2020-02-01)

A Modified Intraperitoneal Chemotherapy Regimen for Ovarian Cancer: Technique and Treatment Outcomes
by: Ji Hyun Kim, et al.
Published: (2021-09-01)

Chemotherapy Associated Ovarian Failure
by: Davide Mauri, et al.
Published: (2020-12-01)

Process scale purification of antibodies /
by: Gottschalk, Uwe
Published: (2009)